Barry McManus
Principal Consultant, Empowerment Quality Engineering
Key Points
- Why clear requirements are the foundation of effective vendor management
- The critical role of risk assessment in technology vendor selection and oversight
- How validation extends far beyond initial implementation
- Key metrics that actually matter when evaluating vendor performance
- Focusing on objective evidence rather than excessive documentation
- Leveraging good software engineering practices to enhance validation efficiency
Tom and Barry uncover managing technology vendors in the clinical trial sector. Barry shares his experience in quality management and computerised system validation, emphasising the importance of risk assessment, monitoring, and oversight in vendor management. Followed by some Myth Busting about validation, advocating for a balanced approach that prioritises quality and compliance while fostering collaboration between stakeholders.
Chapters
About the Guest
Barry McManus
Principal Consultant, Empowerment Quality Engineering
Barry is Principal Consultant for Empowerment Quality Engineering Ltd with 27+ years in Quality Assurance, Software Engineering, and IT Administration. He leads GxP CSV compliance and IT supplier audits globally, performs software lifecycle process improvement, and conducts risk assessments for validation strategies.
Since entering the regulated industry in 2003, Barry has managed QA, QC, and CSV roles while maintaining GxP compliance and actively participates in industry organisations, including RQA's I.T. committee, IEEE, ISACA, and ISPE.
Want to discuss vendor oversight?
Book a consultation with Tom Lazenby to explore how Mayet can support your clinical QA needs.